Table 2 Clinicopathologic outcomes of patients who underwent gastrectomy for gastric cancer using either articulating laparoscopic instruments (ALI group) or a robotic surgical system (robotic group) for lymph node dissection.
Variables | Group | p | |
|---|---|---|---|
ALI (nā=ā88) | Robotic (nā=ā96) | ||
Extent of LN dissection | Ā | Ā | 0.760 |
Ā <āD2 | 56 (63.6) | 59 (61.5) | Ā |
Ā ā„āD2 | 32 (36.4) | 37 (38.5) | Ā |
Extent of gastrectomy | Ā | Ā | 0.945 |
Ā Distal gastrectomy | 73 (83.0) | 80 (83.3) | Ā |
Ā Total gastrectomy | 15 (17.0) | 16 (16.7) | Ā |
Type of reconstruction | Ā | Ā | 0.228 |
Ā Billroth I | 33 (37.5) | 26 (27.1) | Ā |
Ā Billroth II | 38 (43.2) | 53 (55.2) | Ā |
Ā Roux-en-Y | 17 (19.3) | 17 (17.7) | Ā |
Operation time, min | 168.6āĀ±ā48.9 | 186.5āĀ±ā58.6 | 0.026 |
Blood loss, mL | 68.8āĀ±ā61.1 | 61.1āĀ±ā74.8 | 0.502 |
No. of collected LNs | 34.0āĀ±ā13.5 | 36.2āĀ±ā14.4 | 0.289 |
No. of positive LNs | 0.9āĀ±ā2.3 | 1.3āĀ±ā4.5 | 0.422 |
T classification | Ā | Ā | 0.798 |
Ā T1 | 65 | 72 | Ā |
Ā T2 | 4 | 7 | Ā |
Ā T3 | 12 | 10 | Ā |
Ā T4a | 7 | 7 | Ā |
N classification | Ā | Ā | 0.167 |
Ā N0 | 71 | 73 | Ā |
Ā N1 | 7 | 11 | Ā |
Ā N2 | 6 | 7 | Ā |
Ā N3a | 4 | 1 | Ā |
Ā N3b | 0 | 4 | Ā |
